Royal Bank of Canada’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $184K | Buy |
1,661
+1,599
| +2,579% | +$145K | ﹤0.01% | 5045 |
|
|
2026
Q1 | $5K | Sell |
62
-1,614
| -96% | -$157K | ﹤0.01% | 6441 |
|
|
2025
Q4 | $180K | Sell |
1,676
-124,110
| -99% | -$13.2M | ﹤0.01% | 4830 |
|
|
2025
Q3 | $12.7M | Sell |
125,786
-70,450
| -36% | -$6.54M | ﹤0.01% | 1974 |
|
|
2025
Q2 | $12.4M | Buy |
196,236
+196,105
| +149,698% | +$12M | ﹤0.01% | 1868 |
|
|
2025
Q1 | $7K | Sell |
131
-1,083
| -89% | -$60.1K | ﹤0.01% | 6273 |
|
|
2024
Q4 | $68K | Sell |
1,214
-5,071
| -81% | -$280K | ﹤0.01% | 5539 |
|
|
2024
Q3 | $328K | Buy |
6,285
+836
| +15% | +$40.1K | ﹤0.01% | 4431 |
|
|
2024
Q2 | $223K | Buy |
5,449
+4,005
| +277% | +$160K | ﹤0.01% | 4673 |
|
|
2024
Q1 | $63K | Sell |
1,444
-14,688
| -91% | -$643K | ﹤0.01% | 5436 |
|
|
2023
Q4 | $743K | Buy |
16,132
+4,089
| +34% | +$129K | ﹤0.01% | 3913 |
|
|
2023
Q3 | $276K | Buy |
12,043
+4,794
| +66% | +$107K | ﹤0.01% | 4524 |
|
|
2023
Q2 | $120K | Buy |
7,249
+5,286
| +269% | +$95.4K | ﹤0.01% | 5186 |
|
|
2023
Q1 | $35K | Buy |
1,963
+1,789
| +1,028% | +$44.9K | ﹤0.01% | 5803 |
|
|
2022
Q4 | $5K | Buy |
174
+109
| +168% | +$2.8K | ﹤0.01% | 6744 |
|
|
2022
Q3 | $2K | Buy |
+65
| New | +$1.21K | ﹤0.01% | 7060 |
|
|
2022
Q2 | – | Sell |
-2,796
| Closed | -$32K | – | 7669 |
|
|
2022
Q1 | $32K | Sell |
2,796
-5,735
| -67% | -$50.3K | ﹤0.01% | 6352 |
|
|
2021
Q4 | $85K | Buy |
8,531
+3,951
| +86% | +$44.4K | ﹤0.01% | 6051 |
|
|
2021
Q3 | $60K | Buy |
4,580
+363
| +9% | +$5.54K | ﹤0.01% | 6055 |
|
|
2021
Q2 | $83K | Buy |
4,217
+402
| +11% | +$8.35K | ﹤0.01% | 5730 |
|
|
2021
Q1 | $81K | Buy |
3,815
+3,160
| +482% | +$91.6K | ﹤0.01% | 5597 |
|
|
2020
Q4 | $20K | Buy |
655
+455
| +228% | +$11.6K | ﹤0.01% | 6072 |
|
|
2020
Q3 | $4K | Buy |
+200
| New | +$4.58K | ﹤0.01% | 6187 |
|
|
2020
Q2 | – | Sell |
-121
| Closed | -$2K | – | 6870 |
|
|
2020
Q1 | $2K | Sell |
121
-1,631
| -93% | -$29.2K | ﹤0.01% | 6325 |
|
|
2019
Q4 | $40K | Buy |
+1,752
| New | +$38.9K | ﹤0.01% | 5545 |
|
|
2019
Q2 | – | Sell |
-5
| Closed | – | – | 7130 |
|
|
2019
Q1 | $0 | Buy |
5
+3
| +150% | +$86 | ﹤0.01% | 7049 |
|
|
2018
Q4 | $0 | Sell |
2
-424
| -100% | -$11.7K | ﹤0.01% | 7058 |
|
|
2018
Q3 | $12K | Buy |
426
+380
| +826% | +$12K | ﹤0.01% | 5911 |
|
|
2018
Q2 | $1K | Buy |
+46
| New | +$1.26K | ﹤0.01% | 6386 |
|
|
2018
Q1 | – | Sell |
-106
| Closed | -$3K | – | 6728 |
|
|
2017
Q4 | $3K | Buy |
+106
| New | +$2.8K | ﹤0.01% | 6209 |
|
Other funds holding RYTM
RCM
BBA
PA
Royal Bank of Canada's RYTM Position: Q2 2026 in Review
Royal Bank of Canada increased its Rhythm Pharmaceuticals (RYTM) stake by 2,579% in Q2 2026, buying an estimated $145K and bringing the position to 1,661 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #5045.
Royal Bank of Canada first reported a position in RYTM in Q4 2017 and has held it in 30 quarters since. The position peaked at $12.7M in Q3 2025. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.
- Royal Bank of Canada held 1,661 shares of Rhythm Pharmaceuticals worth $184K as of Q2 2026.
- Royal Bank of Canada bought 1,599 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $145K.
- Rhythm Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5045 holding.
- Royal Bank of Canada first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 30 quarters since.
- Royal Bank of Canada's Rhythm Pharmaceuticals position peaked at $12.7M in Q3 2025.
- 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.